Irene Kang

963 total citations
44 papers, 592 citations indexed

About

Irene Kang is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Irene Kang has authored 44 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 25 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Irene Kang's work include Cancer Genomics and Diagnostics (14 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Cells and Metastasis (6 papers). Irene Kang is often cited by papers focused on Cancer Genomics and Diagnostics (14 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Cells and Metastasis (6 papers). Irene Kang collaborates with scholars based in United States, Switzerland and South Korea. Irene Kang's co-authors include Brent A. Craven, Rehan M Khan, Noam Sobel, Benjamin Judkewitz, Jess Porter, Gary S. Settles, Joanne Mortimer, George J. Salem, Fred R. Sattler and Kyuwan Lee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature Neuroscience.

In The Last Decade

Irene Kang

39 papers receiving 574 citations

Peers

Irene Kang
Comparison fields: 5 of 105
  • Oncology 183
  • Sensory Systems 159
  • Cellular and Molecular Neuroscience 103
  • Biomedical Engineering 93
  • Pulmonary and Respiratory Medicine 80
Y Liu China
Jeffrey A. Winfield United States
P Henry United Kingdom
Kazuya Kawabata Japan
Eiko Honda Japan
Tina C. Huang United States
Heming Wang United States
Karen Wu United States
Timo Wirth Germany
Joseph A. Cioffi United States
Y Liu China View profile →
Citations per field, relative to Irene Kang
Irene Kang · 1×
Citations per year, relative to Irene Kang
Irene Kang · 1×

Countries citing papers authored by Irene Kang

Since Specialization
Citations

This map shows the geographic impact of Irene Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Kang more than expected).

Fields of papers citing papers by Irene Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Kang. The network helps show where Irene Kang may publish in the future.

Co-authorship network of co-authors of Irene Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Kang. A scholar is included among the top collaborators of Irene Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Kang. Irene Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 8
2 2
3 5
4 1
5 1
6 3
7 0
8 17
9 20
10 5
11 4
12 2
13 1
14 37
15 59
16 16
17 13
18 44
19 12
20 249

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026